Germline pathogenic or likely pathogenic variants in homologous recombination-deficiency (HRD) genes were found in 42% (16/38) of patients, predominantly in BRCA1 (81%, 13/16). This evidence concerns the gene BRCA1 and hypoparathyroidism-retardation-dysmorphism syndrome.